AI TOOL PROFILE

Clario: Clinical Trial Endpoint Technology

Clario helps pharmaceutical, biotech, and medical device companies collect and analyze clinical trial data. It is designed for teams requiring endpoint technology across site-based, hybrid, or decentralized trial models.

Pricing

Pricing was not clearly available from the provided evidence. Buyers should confirm current pricing on the vendor website.

At a glance

Best for
Pharmaceutical companies, Biotechnology firms, Medical device manufacturers, Contract Research Organizations (CROs)
Key use cases
Cardiac Safety Monitoring, Mobility Endpoint Measurement, Decentralized Trial Execution, Clinical Imaging Management
Visit clarioclario software interface screenshot

How AI is used

Clario is a clinical trial endpoint technology provider that captures and manages data for drug and device development. The platform uses hardware and software to monitor biological and physiological endpoints across various therapeutic areas, including oncology and neuroscience.

The service is designed for sponsors, contract research organizations (CROs), and clinical sites. It supports the collection of cardiac safety data, respiratory function, and precision motion, as well as the management of electronic clinical outcome assessments (eCOA).

Buyers can use the platform to manage participant screening through eligibility solutions and supports compliance with data privacy standards such as GDPR and 21 CFR Part 11. The platform includes AI-assisted tools for interpreting spirometry tests and redacting patient identifiers from imaging files.

Buyers should confirm which specific endpoint modalities are required for their study and evaluate if the global operational infrastructure aligns with their specific country-level regulatory needs.

Key Features

  • Cardiac Safety Solutions

    Supports continuous ECG data collection and ambulatory blood pressure monitoring for clinical trials.

  • eCOA Platform

    Electronic clinical outcome assessments for global trials, including specialized tools for neuroscience and suicide ideation monitoring.

  • Medical Imaging Core Lab

    Centralized services for processing and analyzing modalities including CT scans, MRIs, and endoscopies.

  • Precision Motion Analysis

    Uses Opal wearable sensor technology to measure objective digital endpoints of patient mobility.

  • Respiratory Solutions

    Provides site-based and virtual home spirometry testing and lung sound assessment.

  • Image Redact AI

    Automatically redacts patient identifiers from photos, videos, and PDFs.

  • Trial Enablement Tools

    Cloud-native software for participant screening, eligibility management, and data reporting.

Use Cases

  • Cardiac Safety Monitoring

    Collecting and analyzing continuous ECG data to assess safety and efficacy in site-based or hybrid trials.

  • Mobility Endpoint Measurement

    Using wearable sensors to capture digital endpoints related to functional mobility in research settings.

  • Decentralized Trial Execution

    Using eCOA and virtual spirometry to support at-home participant assessments.

  • Clinical Imaging Management

    Collecting and storing de-identified medical images for compliance with regulatory standards.

FAQ

What types of data can Clario collect for clinical trials?

Clario collects endpoint data, including continuous ECG, blood pressure, respiratory function via spirometry, medical imaging, and mobility data via wearable sensors.

Does Clario support decentralized clinical trials (DCTs)?

Yes, Clario provides tools for hybrid and decentralized trials, including eCOA solutions and virtual home spirometry to support at-home patient assessments.

How does Clario use AI in its platform?

Clario uses AI to assist in interpreting spirometry tests and through Image Redact AI, which removes patient identifiers from imaging files.

Source category: Healthcare

Source subcategory: Clinical Trial Software

More tools in Healthcare

Other published listings in the Healthcare category.

Browse all tools in Healthcare